Cordiamine, 250 mg/ml 2 ml 10 pcs

Collapse, asphyxia (including newborns), shock during surgery and in the postoperative period, respiratory and circulatory depression in infectious diseases.

Indications

Collapse, asphyxia (including newborns), shock during surgical
operations and in the postoperative period, respiratory depression and
blood circulation in infectious diseases.

Pharmacological effect

Pharmacotherapeutic group.

Special instructions

In case of an overdose of niketamide, convulsions are possible.

Active ingredient

Niketamide

Composition

1 ml of the drug contains:

active ingredient – niketamide 250.0 mg;

excipient – water for injection up to 1.0 ml.

Pregnancy

There is no reliable data on the safety of using the drug during pregnancy and lactation.

Contraindications

Hypersensitivity to the components of the drug;

Decreased seizure threshold, seizures (including history);

Hyperthermia in children;

Pregnancy, lactation period.

Side Effects

From the digestive system: vomiting.
From the nervous system: anxiety, muscle contractions (starting from the orbicularis oris muscles).
From the skin: itching, facial flushing.
From the cardiovascular system: arrhythmia.
Other: pain at the injection site, allergic reactions.

Interaction

The convulsive effect of cordiamine is enhanced by reserpine, the stimulating effect on the respiratory center is eliminated by anesthesia, the effect of the drug is weakened by PAS and saluzide, and aminazine and other phenothiazine derivatives lead to a weakening of the analeptic effect and convulsive effect.

Overdose

Symptoms of overdose: increased severity of dose-dependent side effects, generalized tonic-clonic convulsions.

Measures to assist in case of overdose: symptomatic treatment (including anticonvulsants).

Storage conditions

In a place protected from light, at a temperature not exceeding 15 °C.

Shelf life

3 years.

Manufacturer

Ellara LLC, Russia